The Storz Professional Image Enhancement System (SPIES) nonmuscle-invasive bladder cancer study: A multicenter international randomized controlled study

Journal of Endourology

Volumn 28, Issue 11, 2014, Pages 1253-1255

  Gravas, Stavros ^a   Stenzl, Arnulf ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CANCER RECURRENCE; FOLLOW UP; GOOD CLINICAL PRACTICE; HUMAN; IMAGING SYSTEM; MULTICENTER STUDY; NON MUSCLE INVASIVE BLADDER CANCER; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROFESSIONAL IMAGE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SHORT SURVEY; TRANSITIONAL CELL CARCINOMA; CARCINOMA, TRANSITIONAL CELL; CLINICAL TRIAL; CONTROLLED STUDY; IMAGE ENHANCEMENT; PROCEDURES; RANDOMIZED CONTROLLED TRIAL; URINARY BLADDER NEOPLASMS;

CARCINOMA, TRANSITIONAL CELL; HUMANS; IMAGE ENHANCEMENT; URINARY BLADDER NEOPLASMS;

EID: 84929513789     PISSN: 08927790     EISSN: 1557900X     Source Type: Journal    
DOI: 10.1089/end.2014.1651     Document Type: Short Survey

References (3)

1. Stenzl A, Burger M, Fradet Y, et al. Hexaminolevulinate guided fluorescence cystoscopy reduces recurrence in patients with nonmuscle invasive bladder cancer. J Urol 2010;184:1907-1913.
2. Cauberg EC, de Bruin DM, Faber DJ, et al. A new generation of optical diagnostics for bladder cancer: Technology, diagnostic accuracy, and future applications. Eur Urol 2009;56:287-296.
3. de la Rosette JJ, Gravas S. A multi-center, randomized international study to compare the impact of narrow band imaging versus white light cystoscopy in the recurrence of bladder cancer. J Endourol 2010;24:660-661.